Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge

Modified vaccinia Ankara virus (MVA) is a smallpox vaccine candidate. This study was performed to determine if MVA vaccination provides long-term protection against rabbitpox virus (RPXV) challenge, an animal model of smallpox. Two doses of MVA provided 100% protection against a lethal intranasal RP...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Vaccine Immunol
Autors principals: Jones, Dorothy I., McGee, Charles E., Sample, Christopher J., Sempowski, Gregory D., Pickup, David J., Staats, Herman F.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2016
Matèries:
Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933771/
https://ncbi.nlm.nih.gov/pubmed/27146001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00216-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars